Sign In
Buy VERX
$12.91
+0.310 (+2.46%)
At Close: Jul 31, 2026
Vertex Pharmaceuticals: Prepared To Defend Their Dominance And Expand Their Expertise
11:59pm, Tuesday, 30'th Dec 2025
Vertex Pharmaceuticals remains a 'Top Idea' with robust Q3 earnings, a dominant CF franchise, and a broadening late-stage pipeline. VRTX's diversification into pain, kidney, cell, and gene therapies p
Vertex, Inc. (NASDAQ:VERX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
02:18am, Friday, 26'th Dec 2025
Vertex, Inc. (NASDAQ: VERX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eighteen analysts that are presently covering the stock, Marketbeat reports. One investment ana
Why a 63% Vertex Selloff Didn't Scare Off a New $13 Million Investor
01:19pm, Wednesday, 24'th Dec 2025
New York City-based Hyperion Capital Advisors initiated a stake in Vertex during the third quarter, buying up 540,000 shares. The shares were worth about $13.39 million at quarter-end.
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
04:00pm, Monday, 22'nd Dec 2025
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 44th Annual J.P. Mor
Aperture Investors LLC Purchases 76,223 Shares of Vertex, Inc. $VERX
03:25am, Wednesday, 10'th Dec 2025
Aperture Investors LLC lifted its holdings in shares of Vertex, Inc. (NASDAQ: VERX) by 11.8% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Ex
Vertex Stock: Why One Fund Lifted Its $94.3 Million Position Even as Shares Sank
01:00pm, Sunday, 07'th Dec 2025
California-based Tensile Capital Management increased its position in Vertex by 160,559 shares in the third quarter. Despite the increase in shares, the position value fell by about $34.4 million from
Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?
07:15pm, Saturday, 06'th Dec 2025
Vertex Pharmaceuticals is the worldwide leader in cystic fibrosis treatment -- and its drugs have generated blockbuster revenue. The company has expanded into other therapeutic areas in recent years a
Vertex's gene therapy shows promise in younger children with blood disorders
07:04am, Saturday, 06'th Dec 2025
Vertex Pharmaceuticals said on Saturday its gene therapy helped children aged between 5 and 11 years with sickle cell disease to be free of painful events and allowed those with another blood disorder
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in pe
Vertex and CPA.com Announce AI-Driven Expansion of Tax Compliance Services for Accounting Firms
08:00am, Friday, 05'th Dec 2025
KING OF PRUSSIA, Pa., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, and CPA.com, the trusted pa
1 Reason I'll Never Sell Vertex Pharmaceuticals Stock
03:10pm, Thursday, 04'th Dec 2025
Vertex Pharmaceuticals dominates the cystic fibrosis treatment market and recently has expanded into other therapeutic areas. The biotech predicts full-year 2025 revenue of as much as $12 billion.
Vertex Up 9.2% in 3 Months: Should You Buy, Sell or Hold the Stock?
10:06am, Wednesday, 03'rd Dec 2025
VRTX rises 9.2% in three months but trails its industry as mixed new-drug sales and tightened 2025 guidance cloud near-term momentum.
Vertex, Inc. (NASDAQ:VERX) Given Average Rating of “Moderate Buy” by Analysts
01:46am, Monday, 01'st Dec 2025
Vertex, Inc. (NASDAQ: VERX - Get Free Report) has received an average recommendation of "Moderate Buy" from the eighteen analysts that are currently covering the company, Marketbeat.com reports. One e
Bank of New York Mellon Corp Has $7.13 Million Stock Holdings in Vertex, Inc. $VERX
05:06am, Saturday, 22'nd Nov 2025
Bank of New York Mellon Corp lifted its stake in shares of Vertex, Inc. (NASDAQ: VERX) by 14.7% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The i
Bank Julius Baer & Co. Ltd Zurich Sells 51,003 Shares of Vertex, Inc. $VERX
04:08am, Saturday, 22'nd Nov 2025
Bank Julius Baer and Co. Ltd Zurich lowered its stake in Vertex, Inc. (NASDAQ: VERX) by 34.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and E
